The gradual dose escalation from 2.5 mg to higher doses over several months is designed to minimize gastrointestinal side effects like nausea, vomiting, and diarrhea, not to build up drug levels
You are not a good candidate for a GLP-1 agonist if you have any of the following: diabetic retinopathy, low blood sugar, decreased kidney function, pancreatitis, medullary thyroid cancer (or a family history of medullary thyroid carcinoma), or multiple endocrine neoplasia type 2 These medications work in several ways but, simply put, they slow digestion and increase how full you feel after eating
The table summarizes the pharmacokinetic data (mean SD mol/L) after the first dose of levocarnitine injection and after 8 weeks of levocarnitine injection therapy
This commitment to bioavailability is what sets our formulations apart
Frequently Asked Questions See Whether You Qualify for GLP-1 Treatment Complete a 5-minute intake so a licensed provider can review your health history, weight goals, and whether GLP-1 treatment may be appropriate.